BML264
BML264 ((E) -N- (p-amylcinnamoyl) anthranilic acid) is an agonist for TREK-1. BML264 can be used to study diseases associated with TASK1 dysfunction[1].
Product Specifications
CAS Number
99196-74-4
Product Name Alternative
(E) -N- (p-Amylcinnamoyl) anthranilic acid; (E) -ACA
UNSPSC
12352005
Hazard Statement
H410
Target
Potassium Channel
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/bml264.html
Smiles
O=C(O)C1=CC=CC=C1NC(/C=C/C2=CC=C(CCCCC)C=C2)=O
Molecular Formula
C21H23NO3
Molecular Weight
337.41
Precautions
P273-P391-P501
References & Citations
[1]Feinmark S, et al., Method of treating a condition associated with phosphorylation of TASK-1. US20070259051 A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog